\nRegencell Bioscience Holdings Ltd., o companie obscur\u0103 de medicin\u0103 tradi\u0163ional\u0103 chinez\u0103, listat\u0103 la bursa din New York, a devenit subiectul uneia dintre cele mai spectaculoase \u015fi controversate raliuri bursiere din acest an, dup\u0103 ce ac\u0163iunile sale au crescut cu peste 82.000% de la minimele atinse \u00een februarie, scrie Bloomberg.<\/p>\n
\nValoarea ac\u0163iunilor a atins un v\u00e2rf ame\u0163itor la \u00eenceputul lunii iunie, propuls\u00e2ndu-l pe CEO-ul Yat-Gai Au, care de\u0163ine aproape \u00eentreaga companie, \u00eentr-un clasament select: pentru scurt timp, el a ajuns s\u0103 se numere printre cele mai bogate 100 de persoane din lume \u2014 cel pu\u0163in pe h\u00e2rtie.<\/p>\n
\n\u00cen v\u00e2rful raliului, atins pe 17 iunie, participa\u0163ia de 86% de\u0163inut\u0103 de Yat-Gai Au valora nu mai pu\u0163in de 33,3 miliarde de dolari, potrivit Bloomberg Billionaires Index \u2014 mai mult dec\u00e2t averile fondatorului Nike, Phil Knight, sau ale magnatului tech Masayoshi Son. \u00cen prezent, averea sa estimat\u0103 a sc\u0103zut la 6,8 miliarde.<\/p>\n
\nCompania spune c\u0103 nimic nu s-a schimbat \u00een modelul de business sau \u00een performan\u0163ele financiare. \u00centr-o raportare intermediar\u0103 transmis\u0103 luni, Regencell a dat vina pe \u201eshort sellerii\u201d pentru volatilitatea f\u0103r\u0103 precedent.<\/p>\n
\nRealitatea financiar\u0103 a companiei contrasteaz\u0103 puternic cu euforia de pe burs\u0103. Regencell are venituri modeste \u015fi pierderi recurente, dezvolt\u00e2nd tratamente alternative pe baz\u0103 de plante pentru ADHD \u015fi autism, afec\u0163iuni pentru care medicina tradi\u0163ional\u0103 chinez\u0103 nu are, \u00een mod general acceptat, solu\u0163ii demonstrate \u015ftiin\u0163ific.<\/p>\n
\nDup\u0103 v\u00e2rful atins, ac\u0163iunile companiei s-au pr\u0103bu\u015fit cu peste 80%, \u00eentr-un declin care a st\u00e2rnit semne de \u00eentrebare \u00een r\u00e2ndul anali\u015ftilor \u015fi al autorit\u0103\u0163ilor de reglementare.<\/p>\n
\nSecurities and Exchange Commission (SEC), institu\u0163ia american\u0103 care reglementeaz\u0103 pie\u0163ele financiare, a refuzat s\u0103 comenteze situa\u0163ia, iar Regencell nu a r\u0103spuns la solicit\u0103rile presei.<\/p>\n
\n\u00centre timp, pia\u0163a r\u0103m\u00e2ne derutat\u0103: o companie necunoscut\u0103, cu pierderi continue \u015fi venituri minime, ajunge pentru scurt timp la o capitalizare comparabil\u0103 cu cea a unor gigan\u0163i din S&P 500 \u2014 un episod care ridic\u0103 semne de \u00eentrebare serioase despre eficien\u0163a \u015fi transparen\u0163a bursei americane.<\/p>\n","protected":false},"excerpt":{"rendered":"
Regencell Bioscience Holdings Ltd., o companie obscur\u0103 de medicin\u0103 tradi\u0163ional\u0103 chinez\u0103, listat\u0103 la bursa din New York, a devenit subiectul uneia dintre cele mai spectaculoase \u015fi controversate raliuri bursiere din acest an, dup\u0103 ce ac\u0163iunile sale au crescut cu peste 82.000% de la minimele atinse \u00een februarie, scrie Bloomberg. Valoarea ac\u0163iunilor a atins un v\u00e2rf […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[7172,279,368,235,125,272,246,9863,26190,80],"class_list":["post-238060","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-actiuni","tag-bogati","tag-burse","tag-business","tag-ceo","tag-companie","tag-crestere","tag-hartie","tag-raliu","tag-refuz"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/238060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=238060"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/238060\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=238060"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=238060"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=238060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}